Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482141 · ClinicalTrials.gov registry record · NA
Clinical Utility of Prenatal Whole Exome Sequencing
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
NCT03482141 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 316 participants.
The verdict
NCT03482141, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
Study Summary
The investigator aims to examine the clinical utility of WES, including assessment of a variety of health-related and reproductive outcomes in undiagnosed prenatal cases.
Interventions
- DEVICE Whole Exome Sequencing (WES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2022-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03482141
The ClinicalTrials.gov registry entry for NCT03482141 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole Exome Sequencing (WES) is the first listed.
NCT03482141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03482141 about?
NCT03482141 is a clinical study titled "Clinical Utility of Prenatal Whole Exome Sequencing". The investigator aims to examine the clinical utility of WES, including assessment of a variety of health-related and reproductive outcomes in undiagnosed prenatal cases.
What is the current status of trial NCT03482141?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2017-08-01. Estimated completion is 2022-05-13.
What interventions are being tested in trial NCT03482141?
The interventions under investigation include: Whole Exome Sequencing (WES) (DEVICE).
Who is sponsoring clinical trial NCT03482141?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.